載入...

Overcoming resistance to targeted therapies in NSCLC: current approaches and clinical application

The discovery that a number of aberrant tumorigenic processes and signal transduction pathways are mediated by druggable protein kinases has led to a revolutionary change in nonsmall cell lung cancer (NSCLC) treatment. Epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) are...

全面介紹

Na minha lista:
書目詳細資料
發表在:Ther Adv Med Oncol
Main Authors: Maione, Paolo, Sacco, Paola Claudia, Sgambato, Assunta, Casaluce, Francesca, Rossi, Antonio, Gridelli, Cesare
格式: Artigo
語言:Inglês
出版: SAGE Publications 2015
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC4543855/
https://ncbi.nlm.nih.gov/pubmed/26327924
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834015595048
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!